Skip to main content

Uterine Fibroids clinical trials at UCLA

2 in progress, 1 open to eligible people

Showing trials for
  • Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids

    open to eligible females ages 18-50

    The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.

    Los Angeles, California and other locations

  • Post Market TRUST - U.S.A. Study

    Sorry, in progress, not accepting new patients

    This Post Market study is being conducted to compare the direct and indirect cost of three approaches (GFA, myomectomy, and uterine artery embolization) for the treatment of symptomatic uterine fibroids. In addition, data from this study is being used to satisfy the requirements of the United States Food and Drug Administration's 522 (post market surveillance) order.

    Santa Monica, California and other locations

Our lead scientists for Uterine Fibroids research studies include .

Last updated: